Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-10

FDA Approved: TOPIRAMATE — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Teva's original application for topiramate, making a generic version of the anti-seizure and migraine-prophylaxis medication available in the U.S.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

ORIG AP for TOPIRAMATE (TOPIRAMATE)